A Case of Hyperphosphatemia and Elevated Fibroblast Growth Factor 23: A Brief Review of Hyperphosphatemia and Fibroblast Growth Factor 23 Pathway

A Case of Hyperphosphatemia and Elevated Fibroblast Growth Factor 23: A Brief Review of Hyperphosphatemia and Fibroblast Growth Factor 23 Pathway

Bibliographic Details
Main Authors:	Joseph Wang, Beth Vogt, Sidharth Kumar Sethi, Matthew G. Sampson, Virginia Vega-Warner, Edgar A. Otto, Rupesh Raina
Format:	Article
Language:	English
Published:	Elsevier 2017-11-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024917301213

Similar Items

Association between serum fibroblast growth factor‐23 concentration and development of hyperphosphatemia in normophosphatemic dogs with chronic kidney disease
by: Hirosumi Miyakawa, et al.
Published: (2021-09-01)

The serum level of the morphogenetic protein fibroblast growth factor 23 (FGF-23) as a marker for the efficiency of hyperphosphatemia therapy with phosphate-binding agents in chronic kidney disease
by: N A Mukhin, et al.
Published: (2016-04-01)

Hyperphosphatemia and Cardiovascular Disease
by: Chao Zhou, et al.
Published: (2021-03-01)

Hyperphosphatemia in chronic kidney disease
by: S. A. Martynov, et al.
Published: (2019-10-01)

Physiological Actions of Fibroblast Growth Factor-23
by: Reinhold G. Erben
Published: (2018-05-01)

Upstream Regulators of Fibroblast Growth Factor 23
by: Danielle M. A. Ratsma, et al.
Published: (2021-02-01)

PKC regulates the production of fibroblast growth factor 23 (FGF23).
by: Ludmilla Bär, et al.
Published: (2019-01-01)

Fibroblast Growth Factor-23 (FGF-23) e Sindrome Cardiorenale
by: Luca Di Lullo, et al.
Published: (2015-03-01)

Control of hyperphosphatemia and maintenance of calcemia in CKD
by: Aluizio Barbosa Carvalho, et al.
Published: (2021-12-01)

Hyperphosphatemia: The risk factor for adverse outcome in maintenance hemodialysis patients
by: Petrović Dejan, et al.
Published: (2012-01-01)

Role of Fibroblast Growth Factor 23 (FGF23) and αKlotho in Cancer
by: Franz Ewendt, et al.
Published: (2021-01-01)

Plasma Fibroblast Growth Factor 23 Is Elevated in Pediatric Primary Hypertension
by: Yao Lin, et al.
Published: (2019-04-01)

Hyperphosphatemia increases inflammation to exacerbate anemia and skeletal muscle wasting independently of FGF23-FGFR4 signaling
by: Brian Czaya, et al.
Published: (2022-03-01)

Hyperphosphatemia is associated with high mortality in severe burns.
by: George Kuo, et al.
Published: (2018-01-01)

Direct and indirect effects of fibroblast growth factor 23 on the heart
by: Toshiaki Nakano, et al.
Published: (2023-02-01)

Fibroblast Growth Factor-23—A Potential Uremic Toxin
by: Piotr Kuczera, et al.
Published: (2016-12-01)

Significance of Fibroblast Growth Factor 23 in Acute Kidney Injury
by: Nikolina Bašić-Jukić, et al.
Published: (2015-01-01)

Role of Fibroblast Growth Factor-23 in Innate Immune Responses
by: Elizabeth A. Fitzpatrick, et al.
Published: (2018-06-01)

Impact of Altered Mineral Metabolism on Pathological Cardiac Remodeling in Elevated Fibroblast Growth Factor 23
by: Maren Leifheit-Nestler, et al.
Published: (2018-06-01)

New Aspects of the Kidney in the Regulation of Fibroblast Growth Factor 23 (FGF23) and Mineral Homeostasis
by: Maria L. Mace, et al.
Published: (2020-11-01)

Role of sclerostin, fibroblast growth factor-23, and Klotho in hemodialysis patients
by: Azza A I. Elmenyawi, et al.
Published: (2019-01-01)

Evaluating the Fibroblast Growth Factor-23 and Phosphate in Iraqi Patients with Acromegaly
by: Sara A. Kashash, et al.
Published: (2024-03-01)

Pathophysiological Implications of Imbalances in Fibroblast Growth Factor 23 in the Development of Diabetes
by: Javier Donate-Correa, et al.
Published: (2021-06-01)

Erythropoietin, Fibroblast Growth Factor 23, and Death After Kidney Transplantation
by: Michele F. Eisenga, et al.
Published: (2020-06-01)

Fibroblast Growth Factor 23 and Osteoporosis: Evidence from Bench to Bedside
by: Wachiranun Sirikul, et al.
Published: (2022-02-01)

Oral Acid Load Down-Regulates Fibroblast Growth Factor 23
by: Angela Vidal, et al.
Published: (2022-02-01)

Serum intact fibroblast growth factor 23 in healthy paediatric population
by: Stanczyk Malgorzata, et al.
Published: (2021-07-01)

Fibroblast growth factor 23 and symmetric dimethylarginine concentrations in geriatric cats
by: Hannah J. Sargent, et al.
Published: (2019-11-01)

The production of fibroblast growth factor 23 is controlled by TGF-β2
by: Martina Feger, et al.
Published: (2017-07-01)

Role of fibroblast growth factor 23 in patients with chronic kidney disease
by: Song-Yan Wang, et al.
Published: (2021-02-01)

Fibroblast growth factor 23 levels before and after renal transplantation
by: Mohamed M El-khatib, et al.
Published: (2016-01-01)

FIBROBLAST GROWTH FACTOR 23 AND KLOTHO PROTEIN IN THE PATHOGENESIS OF SECONDARY HYPERPARATHYROIDISM
by: A V Ilin, et al.
Published: (2013-12-01)

Tumor-induced osteomalacia: Easing the diagnosis with fibroblast growth factor 23
by: Mala Dharmalingam, et al.
Published: (2022-01-01)

Nutritional Guideline for the Management of Mexican Patients with CKD and Hyperphosphatemia
by: Frida Palafox-Serdán, et al.
Published: (2020-10-01)

Phosphate-Trapping Liposomes for Long-Term Management of Hyperphosphatemia
by: Chen Tzror-Azankot, et al.
Published: (2022-11-01)

Cardiovascular problems in dialysis patients - focus on correcting hyperphosphatemia
by: A. M. Essaian, et al.
Published: (2020-10-01)

The Effect of Magnesium Oxide on Hyperphosphatemia in Female Hemodialysis Patients
by: Maryam Pakfetrat, et al.
Published: (2014-07-01)

NPT-IIb Inhibition Does Not Improve Hyperphosphatemia in CKD
by: Tobias E. Larsson, et al.
Published: (2018-01-01)

Variation in the fibroblast growth factor 23 (FGF23) gene associates with serum FGF23 and bone strength in infants
by: Maria Enlund-Cerullo, et al.
Published: (2023-05-01)

Fibroblast Growth Factor-23 (FGF-23) in Dogs—Reference Interval and Correlation with Hematological and Biochemical Parameters
by: Sandra Lapsina, et al.
Published: (2023-10-01)